Cranberry Dosage: How Much A-Type PAC (~36 mg/day)
Educational summary — not medical advice. Cranberry is for reducing the risk of recurrent UTIs, not treating an active infection. See the UTI-prevention page for the warfarin and oxalate cautions. This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
The honest answer
The studied dose is measured in A-type PAC, not total cranberry: about 36 mg of A-type proanthocyanidin per day (BL-DMAC method), taken daily for prevention in people prone to recurrent UTIs. A dose-ranging study points to this level (Howell 2010), and a 2024 meta-analysis found ≥36 mg/day cut risk while lower doses didn't (Xiong 2024). The critical caveat: you usually can't confirm the dose, because labels almost never disclose PAC — only 4 of 13 products we track does.
The key thing most people get wrong: the dose is PAC
Cranberry's benefit for urinary-tract health comes from its A-type proanthocyanidins (PACs), which reduce recurrent-UTI risk by bacterial anti-adhesion — interfering with how E. coli grips the bladder wall. So the research doses in milligrams of A-type PAC, measured by the standardized BL-DMAC method, not grams of cranberry. The dose-ranging work found meaningful anti-adhesion activity in urine at around 36 mg PAC (with 72 mg adding little), which is why 36 mg/day became the reference dose (Howell 2010). The 2024 meta-analysis makes the threshold explicit: trials at ≥36 mg/day reduced risk, trials below it did not (Xiong 2024).
| Question | Answer |
|---|---|
| How much? | ~36 mg A-type PAC/day (BL-DMAC) |
| Threshold? | ≥36 mg/day cut UTI risk; below it, trials showed no effect (Xiong 2024) |
| Any point going higher? | Dose-ranging found 72 mg added little over 36 mg (Howell 2010) |
| How is PAC measured? | BL-DMAC method (calibrated to procyanidin A2) — older assays overstate |
| Prevention or treatment? | Prevention of recurrent UTIs — not for an active infection |
| Can I verify it from the label? | Usually no — PAC is almost never disclosed |
PAC checker: are you actually hitting the studied dose?
This only works if your product discloses A-type PAC — most don't, which is the whole point. If you have a disclosed PAC figure per serving (by BL-DMAC), enter it with your servings per day to see your daily PAC in mg and what % of the 36 mg studied dose you're getting.
Where to find the number: look for an explicit "A-type proanthocyanidins (PAC) ___ mg" on the Supplement Facts panel, ideally noting the BL-DMAC method. If the label only says "25,000 mg equivalent," "600 mg Pacran," or "500 mg concentrate," the PAC is undisclosed — you can't use this, and that's the finding.
How to take it
- Target a disclosed ~36 mg of A-type PAC per day — the threshold where trials showed an effect (Xiong 2024); more adds little (Howell 2010).
- Take it daily, for prevention. The trials dosed cranberry continuously over weeks to months in people prone to recurrent UTIs — it's not a symptom-triggered remedy.
- Prioritize a disclosed PAC figure over a big "equivalent" number. A capsule standardized to a stated PAC mg (BL-DMAC) is the only way to know the dose — see the PAC label trap.
- See a clinician for an active infection. UTI symptoms (burning, urgency, fever) need medical care; cranberry does not treat an established infection.
The verified-dose pick
The honest picks here are the 4 products that both disclose A-type PAC and deliver the studied 36 mg/day — useful precisely because you can verify the dose. The cheapest of them is below; full ranking on best cranberry.
Discloses 36 mg of A-type PAC per daily serving (the studied dose) — and it's NSF Certified. The rare product where cost per active dose is real, at $1.06/day.
As an Amazon Associate we earn from qualifying purchases. Ranked by disclosed PAC, never commissions.
Frequently asked questions
How much cranberry should I take per day?
Measured in A-type PAC: ~36 mg/day (BL-DMAC). A 2024 meta-analysis found ≥36 mg/day cut UTI risk while lower doses didn't (Xiong 2024). It's a daily preventive dose, not a treatment.
Is cranberry for treating or preventing a UTI?
Preventing — reducing the risk of recurrent UTIs. The trials measured fewer infections over time, not clearing an active one. For UTI symptoms, see a clinician; a real infection needs antibiotics.
Why can't I tell how much PAC is in my supplement?
Because labels print "equivalent," Pacran, or concentrate weight, not A-type PAC (measured by BL-DMAC). Only 4 of 13 products we track discloses a PAC figure.
Does more cranberry, or acidifying urine, help?
No. A bigger "equivalent mg" isn't proportional to PAC, and the acidification idea is largely outdated — the mechanism is anti-adhesion. Aim for a disclosed ~36 mg PAC/day.
Does cranberry have side effects, and who should be cautious?
Cranberry is generally well tolerated. Concentrated cranberry tablets can raise urinary oxalate, so use caution if you form calcium-oxalate kidney stones. It may also interact with warfarin (evidence is mixed — monitor your INR or ask your doctor), and remember cranberry is for prevention, not treating an active UTI. Talk to your clinician before starting it if you take medications or have a health condition.
Related
- The PAC label trap — why the big "equivalent" number isn't the dose
- Best cranberry — ranked by disclosure, then cost per day at 36 mg PAC
- Cranberry for UTI prevention — the honest evidence and safety cautions
Sources
- Howell AB, et al. "Dosage effect on uropathogenic Escherichia coli anti-adhesion activity in urine following consumption of cranberry powder standardized for proanthocyanidin content." BMC Infect Dis. 2010. PMID: 20398248
- Xiong Z, et al. "Cranberry supplementation for the prevention of urinary tract infections: a meta-analysis." Front Nutr. 2024. PMID: 39668896
- Williams G, et al. "Cranberries for preventing urinary tract infections." Cochrane Database Syst Rev. 2023. PMID: 37068952 (prevention framing).
- Full product dataset: /cranberry/cost-by-brand.json (CC BY 4.0).